Validation of the French version of the alcohol, smoking and substance involvement screening test (ASSIST) in the elderly

Abstract

BackgroundSubstance use disorders seem to be an under considered health problem amongst the elderly. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST), was developed by the World Health Organization to detect substance use disorders. The present study evaluates the psychometric properties of the French version of ASSIST in a sample of elderly people attending geriatric outpatient facilities (primary care or psychiatric facilities).MethodsOne hundred persons older than 65 years were recruited from clients attending a geriatric policlinic day care centre and from geriatric psychiatric facilities. Measures included ASSIST, Addiction Severity Index (ASI), Mini-International Neuropsychiatric Interview (MINI-Plus), Alcohol Use Disorders Identification Test (AUDIT), Revised Fagerstrom Tolerance Questionnaire-Smoking (RTQ) and MiniMental State(MMS).ResultsConcurrent validity was established with significant correlations between ASSIST scores, scores from ASI, AUDIT, RTQ, and significantly higher ASSIST scores for patients with a MINI-Plus diagnosis of abuse or dependence. The ASSIST questionnaire was found to have high internal consistency for the total substance involvement along with specific substance involvement as assessed by Cronbach’s α, ranging from 0.66, to 0.89 .ConclusionsThe findings demonstrate that ASSIST is a valid screening test for identifying substance use disorders in elderly.

Evidencia de validez en Chile del Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)

“…El bajo costo de aplicación hace recomendable su uso en la atención primaria de salud, especialmente si se le vincula a una estrategia de intervención y referencia a tratamien- to (Humeniuk et al, 2008;Khan et al, 2012;Organización Mundial de la Salud, 2011;Monteiro, 2013). El presente estudio tiene algunas limitaciones que deben ser tomadas en cuenta.…”

Aplicação do instrumento Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): uma revisão integrativa

“…Many professionals proceeded to the implementation of ASSIST and among them, we highlight different health professionals (53.8%) (5,7,10,(17)(18)(19)21,(23)(24)(25)(26)28,(31)(32) , followed by trained individuals named as interviewers (34.6%) (2,6,8,11,20,22,27,33) , and researchers (authors), which corresponded to 11,5% (9,16,25) . Regarding the database which the studies were obtained, 34.6% (5,7,11,(16)(17)(18)21,23,26) were from PubMed, followed by the CAPES Journal Portal with 26.9% (2,20,22,25,(31)(32)(33) , SciELO with 19.2% (19,24,(27)(28)(29) , LILACS with 15.4% (6,8,9,…”

“…This IRL shows that 34.6% (5,7,11,(16)(17)(18)(19)(20)(21) of the studies came from the PubMed database, followed by CAPES Journals with 26.9% (2,(21)(22)(23)(24)(25)(26) , SciELO with 19.2% (19,24,(27)(28)(29) , Lilacs, with 15.4% (6,(8)(9)30) and Medline, with 3.8% (10) , 19 studies were duplicated in these databases. After selection, 26 studies were intended for analysis.…”

“…The analysis of the included studies highlighted the year 2012, with 30.8% (7,10,(16)(17)(18)27,28,30) of the publications. According to inclusion and exclusion criteria adopted for this IRL, the years 1997 to 2000,2001,2003,2005,2006 and 2011 had no included studies.…”

“…Regarding the level of evidence, the higher prevalence studies referred to those with level IV, that is, cross-sectional studies, which corresponded to 69.2% of the sample (2,(4)(5)(6)(7)(8)(9)(10)16,(18)(19)(20)(23)(24)(27)(28)(29)33) . Many professionals proceeded to the implementation of ASSIST and among them, we highlight different health professionals (53.8%) (5,7,10,(17)(18)(19)21,(23)(24)(25)(26)28,(31)(32) , followed by trained individuals named as interviewers (34.6%) (2,6,8,11,20,22,27,33) , and researchers (authors), which corresponded to 11,5% (9,16,25) . Regarding the database which the studies were obtained, 34.6% (5,7,11,(16)(17)…”